Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Versus Intermittent Nebulization Therapy in Acute Asthma Exacerbation at Emergency Department: A Randomized Controlled Trial

NCT06291740 is registered in ClinicalTrials.gov with Thammasat University as lead sponsor.

NCT NCT06291740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06291740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Versus Intermittent Nebulization Therapy in Acute Asthma Exacerbation at Emergency Department: A Randomized Controlled Trial
Lead sponsor
Thammasat University
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2024
Completion date
May 31, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma exacerbation, emergency department, nebulization